Catalyst Wire Dossier Catalyst Wire Dossier

SelK2

SelK2 · Tetherex Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SelK2, covering 2020-11-24 to 2022-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety and Efficacy of SelK2 on Airway Responses Following Allergen Challenge in Subjects With Asthma (Part 1) and in Subjects With Chronic Obstructive Pulmonary Disease (Part 2) [Phase 2]

See pricing